Clinical Trial Update: Assessment of Wall Thickness in Hypertrophic Cardiomyopathy

View source ↗

Summary

A clinical trial assessing wall thickness in hypertrophic cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: Mayo Clinic | Conditions: Hypertrophic Cardiomyopathy | Status: COMPLETED